Tuesday, May 22, 2012 2:35:30 PM
IMO, the Bold Subject Line needs to be...
changed to "A Possible" Buyout, and here's why.
The rest of the Post is showing why he believes
there is a Buyout in the works, and makes alot
of sense, but its still only speculation.
Add the word "Possible" in front of the Bold context,
and that should make some folks happy, that cant seem
to think on their own, and read the entire post to
under-stand its full meaning.
Everyone has read the PR that came out. This is
Bass's opinion. Everyone needs to decide what it
means to them, rather than making an issue over
another's opinion.
But, if it wasnt this, it would be something else.
VLF
changed to "A Possible" Buyout, and here's why.
The rest of the Post is showing why he believes
there is a Buyout in the works, and makes alot
of sense, but its still only speculation.
Add the word "Possible" in front of the Bold context,
and that should make some folks happy, that cant seem
to think on their own, and read the entire post to
under-stand its full meaning.
Everyone has read the PR that came out. This is
Bass's opinion. Everyone needs to decide what it
means to them, rather than making an issue over
another's opinion.
But, if it wasnt this, it would be something else.
VLF
Buy and Sell at your own Risk. Dont point fingers, and make excuses. After all, wasnt it you that clicked the Buy Button?
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
